• Retour au cours (1) Harper P.S. : What do we mean by genetic testing? J Med Genet 1997 ; 34 : 749-52.
  • Retour au cours (10) Almquist E.W., Bloch M., Brinkman R., Craufurd D., Hayden M.R. : A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. Am J Hum Genet 1999 ; 64 : 1293-304.
  • Retour au cours (2) Huntington's Disease Collaborative Research Group : A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993 ; 72 : 971-83.
  • Retour au cours (3) International Huntington Association and World Federation of Neurology : Ethical issues, policy statement on Huntington disease molecular genetics, and predictive tests. J Med Genet 1990 ; 27 : 34-8.
  • Retour au cours (4) International Huntington Association and World Federation of Neurology : Guidelines for the molecular genetics predictive tests in Huntington disease. Neurology 1994 ; 44 : 1533-6.
  • Retour au cours (5) Tibben A., Frets P.G., van de Kamp J.J.P., et coll. : Presymptomatic DNA-testing for Huntington disease : pretest attitudes and expectations of applicants and their partners in the Dutch program. Am J Med Genet 1993 ; 48 : 10-6.
  • Retour au cours (6) Laccone F., Engel U., Holinski-Feder E., et coll. : DNA analysis of Huntington's disease : five years of experience in Germany, Austrian, and Switzerland. Neurology 1999 ; 53 : 801-6.
  • Retour au cours (7) Harper P.S., Lim C., Craufurd D. : Ten Years of presymptomatic testing for Huntington's disease : the experience of the UK Huntington's Disease Prediction Consortium. J Med Genet 2000 ; 37 : 567-71.
  • Retour au cours (8) Goizet C., Lesca G., Dürr A. : on behalf of the French Group for Presymptomatic Testing in Neurogenetic Disorders. Presymptomatic testing in Huntington’s disease and Autosomal Dominant Cerebellar Ataxias. Neurology 2002 ; 59 : 1330-7.
  • Retour au cours (9) Lawson K., Wiggins S., Green T., Adam S., Bloch M., Hayden M.R : Adverse psychological events occurring in the first year after predictive testing for Huntington's Disease. J Med Genet 1996 ; 33 : 856-62.